Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Medical

SmithKlineBeecham fraudulently abused FDA rules to keep generic forms of Flonase (fluticasone propionate) off the market, maintaining its monopoly and squeezing consumers for the $1 billion allergy drug, an antitrust class action claims in Philadelphia Federal Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...